Mirae Asset Global Investments
TVRD

Mirae Asset Global Investments’s Tvardi Therapeutics TVRD Stock Holding History

Mirae Asset Global Investments’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-589
Closed -$105K – 2603
2024
Q1 		$105K Buy
+589
New +$15.3K ﹤0.01% 2365
2023
Q3 		– Sell
-623
Closed -$63.5K – 2653
2023
Q2 		$63.5K Sell
623
-3
-0.5% -$413 ﹤0.01% 2580
2023
Q1 		$111K Sell
626
-1
-0.2% -$335 ﹤0.01% 2428
2022
Q4 		$242K Buy
627
+77
+14% +$29.2K ﹤0.01% 2234
2022
Q3 		$186K Buy
550
+160
+41% +$58K ﹤0.01% 2364
2022
Q2 		$128K Buy
+390
New +$137K ﹤0.01% 2265

Other funds holding TVRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mirae Asset Global Investments's TVRD Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of Tvardi Therapeutics (TVRD) in Q2 2024, closing a stake of 589 shares — an estimated $105K sold.

Mirae Asset Global Investments first reported a position in TVRD in Q2 2022 and held it in 6 quarters. The position peaked at $242K in Q4 2022. 79 funds tracked by Wall St. Rank hold TVRD as of Q2 2024.

  • Mirae Asset Global Investments reported no remaining Tvardi Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 589 Tvardi Therapeutics shares in Q2 2024, an estimated $105K.
  • Mirae Asset Global Investments first reported a position in Tvardi Therapeutics in Q2 2022 and held it in 6 quarters.
  • Mirae Asset Global Investments's Tvardi Therapeutics position peaked at $242K in Q4 2022.
  • 79 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.